Document Detail


Clinical strategies and animal models for developing senolytic agents.
MedLine Citation:
PMID:  25446976     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Aging is associated with increasing predisposition to multiple chronic diseases. One fundamental aging process that is often operative at sites of the pathology underlying chronic age-related diseases is cellular senescence. Small molecule senolytic agents are being developed. For successful drug development: 1) appropriate animal models of human age-related diseases need to be devised. 2) Models have to be made in which it can be proven that beneficial phenotypic effects are actually caused through clearing senescent cells by putative senolytic agents, as opposed to "off-target" effects of these agents on non-senescent cells. 3) Models are needed to test efficacy of drugs and to uncover potential side effects of senolytic agents. Development of the optimal animal models and clinical trial paradigms for senolytic agents warrants an intensive effort, since senolytic agents, if successful in delaying, preventing, alleviating, or reversing age-related diseases as a group would be transformative.
Authors:
James L Kirkland; Tamara Tchkonia
Related Documents :
22807526 - Fluid balance of elite female basketball players before and during game play.
2684676 - Improving the precision of biological age determinations. part 1: a new approach to cal...
10395366 - Internal consistency and discriminant validity of the luria nebraska neuropsychological...
19409736 - Development of a method to estimate skeletal age at death in adults using the acetabulu...
25209716 - Calliphora vicina (diptera: calliphoridae) pupae: a timeline of external morphological ...
23776826 - Effect of glare on night time driving in alcoholic versus non-alcoholic professional dr...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-10-28
Journal Detail:
Title:  Experimental gerontology     Volume:  -     ISSN:  1873-6815     ISO Abbreviation:  Exp. Gerontol.     Publication Date:  2014 Oct 
Date Detail:
Created Date:  2014-12-3     Completed Date:  -     Revised Date:  2014-12-3    
Medline Journal Info:
Nlm Unique ID:  0047061     Medline TA:  Exp Gerontol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014. Published by Elsevier Inc.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficient diterpene production in yeast by engineering Erg20p into a geranylgeranyl diphosphate synt...
Next Document:  Hippocampal volume, early cognitive decline and gait variability: Which association?